Sakamoto N - Search Results

1

Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer.

Anai S, Sakamoto N, Sakai Y, Tanaka M, Porvasnik S, Urbanek C, Cao W, Goodison S, Rosser CJ. Anai S, et al. Among authors: sakamoto n. Urol Oncol. 2011 Jul-Aug;29(4):421-9. doi: 10.1016/j.urolonc.2009.04.009. Epub 2009 Jul 3. Urol Oncol. 2011. PMID: 19576799

2

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.

Porvasnik S, Sakamoto N, Kusmartsev S, Eruslanov E, Kim WJ, Cao W, Urbanek C, Wong D, Goodison S, Rosser CJ. Porvasnik S, et al. Among authors: sakamoto n. Prostate. 2009 Sep 15;69(13):1460-9. doi: 10.1002/pros.21008. Prostate. 2009. PMID: 19588526

3

Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells.

Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N, Rosser CJ. Namiki K, et al. Among authors: sakamoto n. PLoS One. 2009 Sep 1;4(9):e6872. doi: 10.1371/journal.pone.0006872. PLoS One. 2009. PMID: 19721714 Free PMC article.

4

Primary seminoma of the prostate.

Hashimoto T, Ohori M, Sakamoto N, Matsubayashi J, Izumi M, Tachibana M. Hashimoto T, et al. Among authors: sakamoto n. Int J Urol. 2009 Dec;16(12):967-70. doi: 10.1111/j.1442-2042.2009.02403.x. Int J Urol. 2009. PMID: 20002841

5

Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients.

Nakagami Y, Ohori M, Sakamoto N, Koga S, Hamada R, Hatano T, Tachibana M. Nakagami Y, et al. Among authors: sakamoto n. Int J Urol. 2010 Jul;17(7):629-34. doi: 10.1111/j.1442-2042.2010.02544.x. Epub 2010 Apr 26. Int J Urol. 2010. PMID: 20438593

6

Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.

Ohno Y, Izumi M, Tachibana M, Kawamura T, Yoshioka K, Aoyagi T, Ohori M, Namiki K, Sakamoto N, Nakagami Y, Hatano T, Akimoto S, Nishimura T. Ohno Y, et al. Among authors: sakamoto n. Oncol Rep. 2008 Sep;20(3):501-9. Oncol Rep. 2008. PMID: 18695898

7

The Long-Term Effect of Intensity Modulated Radiation Therapy for Prostate Cancer on Testosterone Levels.

Horiguchi Y, Tsukuda F, Ogata A, Hagiwara K, Sakamoto N, Hama Y, Koga S. Horiguchi Y, et al. Among authors: sakamoto n. Adv Radiat Oncol. 2021 Nov 17;7(3):100851. doi: 10.1016/j.adro.2021.100851. eCollection 2022 May-Jun. Adv Radiat Oncol. 2021. PMID: 35647399 Free PMC article.

8

Does intensity-modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score-matched analysis.

Tsukuda F, Tanaka Y, Narita S, Shimizu T, Nakasuka S, Hagiwara K, Sakamoto N, Toshihiro K, Horiguchi Y, Koga S. Tsukuda F, et al. Among authors: sakamoto n. Int J Urol. 2024 Apr;31(4):379-385. doi: 10.1111/iju.15373. Epub 2024 Jan 9. Int J Urol. 2024. PMID: 38193565

9

[Retroperitoneal dedifferentiated liposarcoma: a case report].

Gondo T, Ohori M, Nakagami Y, Sakamoto N, Tachibana M. Gondo T, et al. Among authors: sakamoto n. Nihon Hinyokika Gakkai Zasshi. 2007 Sep;98(6):795-9. doi: 10.5980/jpnjurol1989.98.795. Nihon Hinyokika Gakkai Zasshi. 2007. PMID: 17929464 Free article. Japanese.

10

Preoperative prediction of malignant involvement of resected ureters in patients undergoing radical cystectomy for bladder cancer.

Gondo T, Nakashima J, Ohno Y, Hashimoto T, Takizawa I, Sakamoto N, Horiguchi Y, Aoyagi T, Ohori M, Tachibana M. Gondo T, et al. Among authors: sakamoto n. Int J Urol. 2013 May;20(5):501-6. doi: 10.1111/j.1442-2042.2012.03203.x. Epub 2012 Oct 29. Int J Urol. 2013. PMID: 23106193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,406 results

Search Page

Filters